Stockholm May 4, 2020:First result from the research study with one thousand randomely citizens of Stockholm, in Sweden, doing home sampling using Capitainer for Covid-19 immunity The Capitainer qDBS solution is designed to enable convenient and...

    Stockholm, March 11, 2020: The Swedish Medtech start-up, Capitainer, today announced that it has closed a share issue of SEK15 million to commercialise its new dried blood spot sampling solution, Capitainer qDBS. Lead investors are Nordic Consumer Health...

    Capitainer AB, Linköping University and Karolinska University Hospital have been awarded 3M SEK in a joint call; “Samverkansprojekt för bättre hälsa”,  by Vinnova (www.vinnova.se) , Swelife (www.swelife.se) and Medtech4Healths (www.medtech4health.se)....

    Capitainer has had the patent on the novel Capitainer-B product approved in the US and it will shortly be granted. This is a very important step for Capitainer since we see a strong interest from the US market in our product and technology. The novel...

    "The new Capitainer B device "effectively assist in eliminating the hematocrit-based area bias", compared to traditional DBS, independently of the applied blood volume. Take a look at the excellent supporting study by Velghe and Stove.   Read more...

    Capitainer participates in (IATDMCT) Congress 2018, 16–19 September 2018 in Brisbane, Australia The 16th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2018) will be held from Sunday 16th to Wednesday 19th...

    Capitainer participates in AACC Annual Scientific Meeting July29-August 2, 2018 The 70th AACC Annual Scientific Meeting & Clinical Lab Expo is the largest global scientific conference and tradeshow in the field of laboratory medicine. This is part of...

    We have, as per April 30th, had our Novel micro sampling product, the Capitainer B, CE marked and registered with the Swedish Medical Product Agency (Läkemedelsverket). The Capitainer B is registered as an IVD product according to the 98/97EC In vitro...

    Capitainer will participate in Spring Meeting in Clinical Chemistry, 24-26 April 2018 in Uppsala. Welcome to our booth and the seminar entitled "Measuring Peth in capillary blood as a dried blood stain" with Olof Beck, PhD, CSO and co-founder. Time: Wedensdagy 10:...

    Capitainer participates in Medtec Europe 17-19 april 2018, in Stuttgart Germany. Meet us in stand: 10B64 Medtec Europe is the preeminent medical technology platform showcasing the key trends and insights across the entire supply chain of the medical technology...

    Capitainer participates in, and sponsors, the inaugural European symposium on Clinical & Pharmaceutical Solutions through Analysis  -CPSA Europe 2018, in Cambridge, UK. This is part of our strategy to promote the Capitainer concept to the most...

    Capitainer was invited speaker in the diagnostics session at PRINSE’18 (the 5th Printed Intelligense Industry Seminar) this year focusing on ”Manufacturing Solutions for Customer Needs and Vision to the Future”, Jan 31- Feb 1, 2018, in Oulu, Finland. The...

    The board of directors has elected Mr. Ernst Westman as new Chairman of the Board of Capitainer AB. Mr. Westman has been President and CEO of the listed blood diagnostics Boule Diagnostics AB (publ) between 1994 to 2017 and now takes over the leadership in...

Hjärtpatienten Sigvard sitter hemma i köket och förbereder ett blodprov på sig själv. Efter hjärtattacken för ett halvår sedan behandlas han med den blodförtunnande medicinen Waran för att minska risken för återfall. Ett problem med Waran är att doseringen är väldigt...

In an initial funding round, Nordic Consumer Health AB invests 10 million SEK in Capitainer AB. The funds will be used to capitalize the company during the upcoming year and to perform activities in product development, clinical trials and home sampling studies,...

Stockholm, the capital of Sweden, has selected Capitainer as finalist for the Stockholm Innovation Award, an award for Stockholm's most promising business ideas. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome...

Capitainer technology is highlighted as a news article on KTH’s first page. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for further...

Capitainer was selected best Start-Up at the Nordic Pitch Night event Aug 25 in Silicon Valley, USA Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for...

Capitainer has been selected to exhibiting at the Nordic Life Science days Sept. 14-15 in Stockholm. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam...

Capitainer is presenting their technology at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo Aug 1-4, in Philadelphia, USA. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested...

Capitainer is attending the Brighter Startup Program, a one week program for Swedish entrepreneurs located in Silicon Valley’s unique and leading innovation and entrepreneurship ecosystem. Read more news Get In Touch   We are currently seeking funding to reach...

Capitainer is selected as one of few KTH-start-ups to exhibit at the prestigious STING-day on May 28, an investor event gathering Stockholm’s most promising tech start-ups connecting then to VC’s and investors from around the world. Read more news Get In Touch  ...

Capitainer is presenting at the Swedish Clinical Chemistry spring meeting in Malmö May 11-13, Sweden. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam...